Warren Mason
Warren Mason
Princess Margaret Cancer Centre, University of Toronto
Verified email at uhn.ca - Homepage
Cited by
Cited by
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ...
New England journal of medicine 352 (10), 987-996, 2005
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma
J Dalmau, E Tüzün, H Wu, J Masjuan, JE Rossi, A Voloschin, ...
Annals of neurology 61 (1), 25-36, 2007
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ...
New England Journal of Medicine 370 (8), 709-722, 2014
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of …
R Stupp, ME Hegi, WP Mason, MJ Van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and …
R Stupp, WP Mason, MJ Van den Bent, M Weller, B Fisher, MJ Taphoorn, ...
N Engl J Med 352 (10), 987-996, 2005
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
R Vitaliani, W Mason, B Ances, T Zwerdling, Z Jiang, J Dalmau
Annals of Neurology: Official Journal of the American Neurological …, 2005
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ...
Journal of clinical oncology 24 (16), 2563-2569, 2006
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of …
M Petit-Pedrol, T Armangue, X Peng, L Bataller, T Cellucci, R Davis, ...
The Lancet Neurology 13 (3), 276-286, 2014
Changing paradigms—an update on the multidisciplinary management of malignant glioma
R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ...
The oncologist 11 (2), 165-180, 2006
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma
W Wick, VK Puduvalli, MC Chamberlain, MJ Van Den Bent, AF Carpentier, ...
Journal of clinical oncology 28 (7), 1168, 2010
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
TT Batchelor, P Mulholland, B Neyns, LB Nabors, M Campone, A Wick, ...
Journal of Clinical Oncology 31 (26), 3212, 2013
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ...
Journal of Clinical Oncology 15 (8), 2866-2872, 1997
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study
JR Perry, K Bélanger, WP Mason, D Fulton, P Kavan, J Easaw, C Shields, ...
J Clin Oncol 28 (12), 2051-2057, 2010
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
WP Mason, F Graus, B Lang, J Honnorat, JY Delattre, F Valldeoriola, ...
Brain: a journal of neurology 120 (8), 1279-1300, 1997
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
MJB Taphoorn, R Stupp, C Coens, D Osoba, R Kortmann, ...
The lancet oncology 6 (12), 937-944, 2005
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
M Weller, T Gorlia, JG Cairncross, MJ Van Den Bent, W Mason, ...
Neurology 77 (12), 1156-1164, 2011
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ...
The lancet oncology 17 (11), 1521-1532, 2016
The system can't perform the operation now. Try again later.
Articles 1–20